Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities * From research goal to lab ...
Parallel develops AI agents to automate hospital administrative workflows, improving efficiency and reducing manual work ...
MacroMT, the technology platform under Macro Technology Group, today officially announced the completion of a new upgrade to ...
Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities From research goal to lab-ready sequences in hours: Latent-Y compresses ...
Safran Aircraft Engines is ramping up system-level testing for a future open-fan engine as it builds towards full-scale ...
As cross-screen metrics promise clarity, the real impact may lie in how budgets are justified, priced and redistributed, say ...
Workroom Automation, a connected factory platform building the intelligence and automation layer for manufacturing, today announce ...
Qdrant's $50M Series B and version 1.17 release make the case that agentic AI didn't simplify vector search — it scaled the ...
1h
AEM Holdings and ASE Technology Enter Strategic Partnership to Accelerate AI and HPC Test Innovation
ASE subsidiary to subscribe for S$12 million of new AEM sharesSingapore and Taipei, Mar 23, 2026 - (ACN Newswire) - AEM Holdings Ltd. ("AEM" or "the Group"), a global leader in test innovation, announ ...
OpenAI co-founder Andrej Karpathy says December 2025 was the inflection point. The data — and the job market — are beginning ...
Aelis Farma has launched its Phase IIb clinical trial evaluating AEF0217, targeting behavioural and cognitive impairments in ...
AEM Holdings Ltd. (“AEM” or “the Group”), a global leader in test innovation, announced a strategic partnership with ASE Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results